International Journal of Infection

Published by: Kowsar

What Should be Prescribed for Patients with Suspected Multidrug- Resistant Tuberculosis in the Absence of Drug Sensivity Results

Batool Sharifi-Mood 1 , *
Author Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • International Journal of Infection: July 2017, 4 (3); e14137
  • Published Online: May 30, 2017
  • Article Type: Editorial
  • Received: December 2, 2016
  • Accepted: December 14, 2016
  • DOI: 10.5812/iji.14137

To Cite: Sharifi-Mood B. What Should be Prescribed for Patients with Suspected Multidrug- Resistant Tuberculosis in the Absence of Drug Sensivity Results, Int J Infect. 2017 ; 4(3):e14137. doi: 10.5812/iji.14137.

Copyright © 2017, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Metanat M, Sharifi-Mood B, Shahreki S, Dawoudi SH. Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran. Iran Red Crescent Med J. 2012; 14(1): 53-5[PubMed]
  • 2. Yew WW. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects. Kekkaku. 2011; 86(1): 9-16[PubMed]
  • 3. World Health Organization . Guidelines for the programmatic management of drug-resistant tuberculosis. 2008;
  • 4. Hashemi M, Eskandari-Nasab E, Moazeni-Roodi A, Naderi M, Sharifi-Mood B, Taheri M. Association of <I>CTSZ</I> rs34069356 and <I>MC3R</I> rs6127698 gene polymorphisms with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2013; 17(9): 1224-8[DOI]
  • 5. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010; 10(9): 621-9[DOI][PubMed]
  • 6. World Health Organization . The use of molecular line probe assay for the detection of resistnace to second-line anti-tuberculosis drugs. 2013;
  • 7. Yew WW, Chan CK, Leung CC, Chau CH, Tam CM, Wong PC, et al. Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. Chest. 2003; 124(4): 1476-81[PubMed]
  • 8. Jo KW, Lee SD, Kim WS, Kim DS, Shim TS. Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014; 18(1): 39-43
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments